Literature DB >> 11819289

In vitro production of TNF-alpha,IL-6 and sIL-2R in Chinese patients with ulcerative colitis.

Bing Xia, Hai-Jian Guo, JBA Crusius, Chang-Sheng Deng, SGM Meuwissen, AS Pena.   

Abstract

AIM:To determine the tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL-2r) from peripheral blood mononuclear cells (PBMC) in 25 Chinese patients with ulcerative colitis and 20 healthy controls.
METHODS: PBMC were isolated by density gradient centrifugation of heparinized blood and cultures for 24 or 48 hours by stimulation with LPS or PHA. TNF-alphaand sIL-2r were measured by ELISA method and IL-6 measured by biossay.
RESULTS: TNF-alphaproduction stimulated by LPS and sIL-2r production by PHA in ulcerative colitis were significantly lower than in healthy controls (TNF-alpha509(46-7244)ng/L vs 1995(117-18 950)ng/L, P < 0.05; sIL-2r 320U/mlplus minus 165U/ml vs 451U/mlplus minus 247U/ml, P < 0.05).Spontaneous TNF-alphaand sIL-2r production were not significantly different between ulcerative colitis and controls (TNF-alpha304(46-7044)ng/L vs 215(46-4009)ng/L,P > 0.05; sIL-2r 264U/mlplus minus 115U/ml vs 236U/mlplus minus139U/ml, P>0.05). IL-6 production by spontaneous release from PBMC in ulcerative colitis group was 109U/mlplus minus 94U/ml vs 44U/mlplus minus 39U/ml for those in healthy controls, P < 0.01. IL-6 stimulated by LPS in ulcerative colitis group was (261U/ml plus minus 80U/ml) higher than in healthy controls (102U/mlplus minus 54U/ml, P < 0.01). No correlation of TNF-alpha, IL-6, sIL-2r production was found to disease activity, disease location and medication.
CONCLUSION: Cytokine production from PBMC was also disturbed in Chinese patients with ulcerative colitis.

Entities:  

Year:  1998        PMID: 11819289      PMCID: PMC4723470          DOI: 10.3748/wjg.v4.i3.252

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.

Authors:  Y R Mahida; A Gallagher; L Kurlak; C J Hawkey
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

2.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

3.  Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.

Authors:  G A Van Seventer; Y Shimizu; K J Horgan; G E Luce; D Webb; S Shaw
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

4.  Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease.

Authors:  J S Hyams; J E Fitzgerald; W R Treem; N Wyzga; D L Kreutzer
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

5.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

6.  T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.

Authors:  C Mueller; P Knoflach; C C Zielinski
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

7.  Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls.

Authors:  G Bouma; M Oudkerk Pool; J G Scharenberg; J J Kolkman; B M von Blomberg; R J Scheper; S G Meuwissen; A S Peña
Journal:  Scand J Gastroenterol       Date:  1995-11       Impact factor: 2.423

8.  Expression of interleukin-6 by intestinal enterocytes.

Authors:  S C Jones; L K Trejdosiewicz; R E Banks; P D Howdle; A T Axon; M F Dixon; J T Whicher
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

9.  Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.

Authors:  J Brynskov; N Tvede
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

10.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  7 in total

1.  A new chronic ulcerative colitis model produced by combined methods in rats.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 2.  An analysis of 10218 ulcerative colitis cases in China.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 3.  Animal models of inflammatory bowel disease: a review.

Authors:  Nidhi Goyal; Ajay Rana; Abhilasha Ahlawat; Krishna Reddy V Bijjem; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-06-07       Impact factor: 4.473

4.  Expression and significance of nuclear factor kappaB p65 in colon tissues of rats with TNBS-induced colitis.

Authors:  Jun-Hua Li; Jie-Ping Yu; Hong-Gang Yu; Xi-Ming Xu; Liang-Liang Yu; Shi-Quan Liu
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

5.  Effect of cholecystokinin on cytokines during endotoxic shock in rats.

Authors:  Y L Ling; A H Meng; X Y Zhao; B E Shan; J L Zhang; X P Zhang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

6.  Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

Authors:  Shao-Ping Liu; Wei-Guo Dong; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis.

Authors:  Huan-Gan Wu; Xiao Gong; Li-Qing Yao; Wei Zhang; Yin Shi; Hui-Rong Liu; Ye-Jing Gong; Li-Bin Zhou; Yi Zhu
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.